Surgeon-Guided Serratus Block in Breast Reduction Surgery

Not Applicable

Recruiting

• Conditions: Postoperative Pain Control; Breast Reduction

• Registration Number: NCT06905574
• Lead Sponsor: alperen can kokten

Brief Summary

Surgeon guided serratus block, which can be performed by the surgeon in participants undergoing breast reduction surgery, may reduce the sensation of pain from the surgical field in the postoperative period. Thus, participants experience less pain in the postoperative period, consume less analgesics, and there is a decrease in related complications. The aim of this study was to evaluate the effects of the intraoperative surgeon guided serratus block applied on the analgesic consumption of the participants in the first 24 hours after surgery in participants undergoing breast reduction surgery.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-12-01
• Study First Submitted: 2025-02-10
• Status Verified: 2025-03
• Study First Submitted QC: 2025-03-25
• Last Update Submitted: 2025-03-25
• Study First Posted: 2025-04-01
• Last Update Posted: 2025-04-01
• Primary Completion: 2025-06
• Study Completion: 2025-06

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 66

Inclusion Criteria

• Patient's willingness to be included in the study
• 18-65 years
• Woman
• Operated with inferior pedicled breast reduction technique
• The distance from the sternal notch to the nipple complex is between 25-40cm
• ASA I-II
• Breast Usg result BIRADS 1-2
• Patients who have not previously received RT to the breast and have no history of malignancy

Exclusion Criteria

• Patient's request/refusal not to be included in the study
• Previous history of malignancy
• RT story,
• ASA 3-4-5-patient group
• Severe organ failure
• Alcohol, drug addiction
• Bupivacaine allergy
• Diagnosis of psychiatric illness and psychiatric drug use
• Surgery lasting longer than 3 hours
• Bleeding diathesis

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
24 hours postoperatively opioid consumption	24 hours	In the postoperative period, patients will be given opioids according to their pain density with a patient-controlled device, and the daily Morphine consumption in Patient Controlled Analgesia device will be collected and compared between groups.

Secondary Outcome Measures

Name	Time	Method
post-operative acute pain status, post-operative nausea-vomiting status, post-operative NRS determination of pain at rest and in motion determination of complications such as nausea, vomiting, itching, determination of the first PCA analgesic request.	24 hours	Changes in the Numerical Rating Scale (NRS) will be recorded at rest and during movement. The participant's baseline NRS will be recorded, followed by measurements before and after neuraxial positioning and up to 24 hours post-surgery. The NRS is a unidimensional measure of pain intensity in adults. The 11-point numerical scale ranges from '0' representing one end of the pain spectrum (e.g. 'no pain') to '10' representing the other end (e.g. 'worst imaginable pain').

Trial Locations

Locations (1)

Samsun training and research hospital; 🇹🇷 Samsun, Turkey